Taichung, Taiwan

Ying-Chun Lai


Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2017-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Ying-Chun Lai in Cancer Treatment

Introduction

Ying-Chun Lai is a notable inventor based in Taichung, Taiwan. He has made significant contributions to the field of cancer treatment, particularly in enhancing the efficacy of chemotherapeutic drugs. With a total of 2 patents, his work focuses on innovative methods to improve patient outcomes in cancer therapy.

Latest Patents

Ying-Chun Lai's latest patents include a method for improving the effect of the chemotherapeutic drug Gemcitabine on inhibiting pancreatic cancer. This patent also addresses the improvement of side effects associated with Gemcitabine. The probiotic composition disclosed in this patent comprises effective amounts of GMNL-133 and GMNL-89, along with a pharmaceutically acceptable carrier. Notably, GMNL-133 was deposited in the China Center for Type Culture Collection on September 26, 2011, under accession number CCTCC NO. M 2011331, while GMNL-89 was deposited on November 19, 2007, under accession number CCTCC NO. M 207154. Additionally, he has developed a screening method for the rapid identification of hybridomas based on cell size and the expression of exogenous labels, such as fluorescence labeling. This innovative method significantly reduces the time required for antibody development compared to traditional methods.

Career Highlights

Throughout his career, Ying-Chun Lai has worked with prominent organizations, including Genmont Biotech Inc. and Tunghai University. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Ming-Shiou Jan and Wan-Hua Tsai. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.

Conclusion

Ying-Chun Lai's contributions to cancer treatment through his innovative patents demonstrate his commitment to improving patient care. His work continues to influence the field of oncology and offers hope for enhanced therapeutic options for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…